021-51111890
购物车（）
sales@molnova.cn
Cancer-Targeting Compound 1
CAS No. 1007581-62-5
Cancer-Targeting Compound 1 ( —— )
产品货号. M33205 CAS No. 1007581-62-5
Cancer-Targeting Compound 1 可用于与激素相关的癌症研究，摘自专利 WO 2008021331 A2。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥3658 | 有现货 |
|
| 10MG | ￥4902 | 有现货 |
|
| 25MG | ￥7142 | 有现货 |
|
| 50MG | ￥9579 | 有现货 |
|
| 100MG | ￥12663 | 有现货 |
|
| 200MG | ￥17010 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ￥3449 | 有现货 |
|
生物学信息
-
产品名称Cancer-Targeting Compound 1
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Cancer-Targeting Compound 1 可用于与激素相关的癌症研究，摘自专利 WO 2008021331 A2。
-
产品描述Cancer-Targeting Compound 1 is used in the research of hormone-?related cancer, extracted from patent WO 2008021331 A2.
-
体外实验Cancer-Targeting Compound 1 is useful for the research of hormone-related conditions including contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake or synchronizing estrus.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number1007581-62-5
-
分子量299.35
-
分子式C15H13N3O2S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC1(C)COC(=O)N1c1nc(cs1)-c1ccc(cc1)C#N
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Thomas, Joseph, et al. OXAZOLIDONE DERIVATIVES AS PR MODULATORS. WO 2008021331 A2.
产品手册
关联产品
-
3-(3-Methoxyphenyl)p...
3-甲氧基苯丙酸是一种天然存在的代谢物，它是一种有机酸，通过尿液排泄。
-
(-)-Syringaresinol
(-)-丁香脂素源自蒙大拿番荔枝的茎。 (-)-Syringaresinol 通过 G1 期阻滞和诱导细胞凋亡来抑制人早幼粒细胞 HL-60 细胞的增殖，并具有抗癌活性。
-
Notoginsenoside R4
Notoginsenoside R4 is a natural product for research related to life sciences.
